Representatives of governments, healthcare providers, academia and industry from 15 countries gathered in the UK to explore collaborations aimed at developing their local genomics capability.
Healthcare UK, part of the Department of Health, staged the event this week to discuss the challenges around genomics, to showcase British expertise and forge international partnerships in the field.
The work of the research community, backed by the public and private sectors, is helping the UK to lead many advances in genomics.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze